Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-16T23:05:51.031Z Has data issue: false hasContentIssue false

Chapter 73 - Lymphoma and Leukemia in Pregnancy

from Section 12 - Malignant Conditions in Pregnancy

Published online by Cambridge University Press:  23 February 2023

By
Samantha So ,
Amira El-Messidi  and
Elyce H. Cardonick
Edited by
Amira El-Messidi  and
Alan D. Cameron
Amira El-Messidi
Affiliation:
McGill University, Montréal
Alan D. Cameron
Affiliation:
University of Glasgow
Get access

Summary

You are seeing a patient referred by her primary care provider for consultation at your tertiary center’s high-risk obstetrics unit. She is a 27-year-old primigravida at 16+3 weeks’ gestation with intermittent swelling of her arms and face that appears within several minutes of brushing her hair and resolves upon lowering her arms. First-trimester dating sonography was concordant with menstrual dates, and fetal morphology appeared normal, with a low risk of aneuploidy; apart from HIV-negative status, results of other routine baseline prenatal investigations are not yet available to you. She has not experienced abdominal cramps or vaginal bleeding. Her medications include only routine prenatal vitamins.

Keywords

PregnancyLymphoma, Hodgkin’s and non-Hodgkin’sLeukemiaClinical presentationSerum investigationImaging, chest X-ray, fetal considerationsPerinatal risks, complications, maternal-fetal morbidity, adverse outcomeAntepartum, intrapartum, postpartum managementChemotherapyTumor lysis syndrome, eclampsia
Type
Chapter
Information
OSCEs in Obstetrics and Maternal-Fetal Medicine
An Evidence-Based Approach
 , pp. 922 - 936
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Readings

Brenner, B, Avivi, I, Lishner, M. Haematological cancers in pregnancy. Lancet. 2012;379(9815):580–587.CrossRefGoogle ScholarPubMed
Cardonick, EH, Gringlas, MB, Hunter, K, et al. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls. Am J Obstet Gynecol. 2015;212(5):658.Google Scholar
Cardonick, E, Iacobucci, A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283–291.CrossRefGoogle ScholarPubMed
Cohen, JB, Blum, KA. Evaluation and management of lymphoma and leukemia in pregnancy. Clin Obstet Gynecol. 2011;54(4):556–566.Google Scholar
El-Messidi, A, Patenaude, V, Abenhaim, HA. Incidence and outcomes of women with non-Hodgkin’s lymphoma in pregnancy: a population-based study on 7.9 million births. J Obstet Gynaecol Res. 2015;41(4):582–589.CrossRefGoogle Scholar
El-Messidi, A, Patenaude, V, Hakeem, G, et al. Incidence and outcomes of women with Hodgkin’s lymphoma in pregnancy: a population-based study on 7.9 million births. J Perinat Med. 2015;43(6):683–688.CrossRefGoogle Scholar
Evens, AM, Advani, R, Press, OW, et al. Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. J Clin Oncol. 2013;31(32):4132–4139.CrossRefGoogle Scholar
Gurevich-Shapiro, A, Avivi, I. Current treatment of lymphoma in pregnancy. Expert Rev Hematol. 2019;12(6):449–459.CrossRefGoogle ScholarPubMed
Lishner, M, Avivi, I, Apperley, JF, et al. Hematologic malignancies in pregnancy: management guidelines from an international consensus meeting. J Clin Oncol. 2016;34(5):501–508.Google Scholar
Maggen, C, Dierickx, D, Lugtenburg, P, et al. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study. Lancet Haematol. 2019;6(11):e551–e561. [Correction in Lancet Haematol. 2020 Apr;7(4):e279]Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×